C Partners Holding Gmb H Gilead Sciences, Inc. Transaction History

C Partners Holding Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$60.54 - $79.0 $92,384 - $120,554	-1,526 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $104,140 - $115,302	-1,461 Reduced 48.91%	1,526 $118,000
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $21,345 - $24,898	329 Added 12.38%	2,987 $212,000
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $61,404 - $74,858	-843 Reduced 24.08%	2,658 $200,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $249,096 - $292,403	3,501	3,501 $251,000

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of C Partners Holding Gmb H, based on Form 13F filings with the SEC.

Stay updated on C Partners Holding Gmb H with notifications on news.